Literature DB >> 1657143

Fluorescence studies on the interaction of inhibitor 2 and okadaic acid with the catalytic subunit of type 1 phosphoprotein phosphatases.

W D Picking1, W Kudlicki, G Kramer, B Hardesty, J R Vandenheede, W Merlevede, I K Park, A DePaoli-Roach.   

Abstract

Phosphatase inhibitor 2 was mutagenized and expressed in Escherichia coli to produce a protein with a single cysteinyl residue at position 129. The newly introduced sulfhydryl group was labeled with a maleimide derivative of coumarin (CPM). The resulting fluorescent inhibitor 2 molecule (CPM-I2) retains biological activity and binds to the catalytic subunit of type 1 phosphatase (PP1-C) with a Kd similar to the Ki of native I2 (2-3 nM). Fluorescence anisotropy data indicate that kinase FA (glycogen synthase kinase 3) does not dissociate the CPM-I2.PP1-C complex but rather causes a conformational change in the I2 molecule that is retained even after the CPM-I2 is displaced by an excess of native I2. The fluorescence data presented here also indicate that okadaic acid and I2 are competitive for binding to PP1-C, even after kinase FA treatment of the CPM-I2.PP1-C complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657143     DOI: 10.1021/bi00106a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Multiple roles for protein phosphatase 1 in regulating the Xenopus early embryonic cell cycle.

Authors:  D H Walker; A A DePaoli-Roach; J L Maller
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

2.  Characterization of the interaction between DARPP-32 and protein phosphatase 1 (PP-1): DARPP-32 peptides antagonize the interaction of PP-1 with binding proteins.

Authors:  Y G Kwon; H B Huang; F Desdouits; J A Girault; P Greengard; A C Nairn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Dephosphorylation of cdc25-C by a type-2A protein phosphatase: specific regulation during the cell cycle in Xenopus egg extracts.

Authors:  P R Clarke; I Hoffmann; G Draetta; E Karsenti
Journal:  Mol Biol Cell       Date:  1993-04       Impact factor: 4.138

Review 4.  Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend.

Authors:  Kobra Haghighi; Philip Bidwell; Evangelia G Kranias
Journal:  J Mol Cell Cardiol       Date:  2014-10-18       Impact factor: 5.000

5.  IRBIT governs epithelial secretion in mice by antagonizing the WNK/SPAK kinase pathway.

Authors:  Dongki Yang; Qin Li; Insuk So; Chou-Long Huang; Hideaki Ando; Akihiro Mizutani; George Seki; Katsuhiko Mikoshiba; Philip J Thomas; Shmuel Muallem
Journal:  J Clin Invest       Date:  2011-02-07       Impact factor: 14.808

6.  Redirecting SR Protein Nuclear Trafficking through an Allosteric Platform.

Authors:  Brandon E Aubol; Kendra L Hailey; Laurent Fattet; Patricia A Jennings; Joseph A Adams
Journal:  J Mol Biol       Date:  2017-05-31       Impact factor: 5.469

7.  Structural diversity in free and bound states of intrinsically disordered protein phosphatase 1 regulators.

Authors:  Joseph A Marsh; Barbara Dancheck; Michael J Ragusa; Marc Allaire; Julie D Forman-Kay; Wolfgang Peti
Journal:  Structure       Date:  2010-09-08       Impact factor: 5.006

8.  Detailed structural characterization of unbound protein phosphatase 1 inhibitors.

Authors:  Barbara Dancheck; Angus C Nairn; Wolfgang Peti
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

9.  Identification of two steps during Xenopus ribosomal gene transcription that are sensitive to protein phosphorylation.

Authors:  P Labhart
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  Molecular interactions connecting the function of the serine-arginine-rich protein SRSF1 to protein phosphatase 1.

Authors:  Brandon E Aubol; Pedro Serrano; Laurent Fattet; Kurt Wüthrich; Joseph A Adams
Journal:  J Biol Chem       Date:  2018-09-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.